Search Reports
Categories
Categories

Global DTaP and Tdap Vaccines Market

Global DTaP and Tdap Vaccines Market Research Report 2025(Status and Outlook)

Report Code : PHA0954
Published Date : 17 July, 1905 | No of Pages: 151

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
DTaP and Tdap vaccines are immunizations designed to protect against three bacterial diseases: diphtheria, tetanus, and pertussis (whooping cough). The DTaP vaccine is typically administered to infants and young children in a series of doses, starting at two months of age, to build immunity against these diseases. On the other hand, the Tdap vaccine is a booster shot that is given to adolescents and adults to maintain immunity, especially against pertussis. The Tdap vaccine is also recommended for pregnant women during each pregnancy to protect the newborn from whooping cough. Both vaccines contain inactivated or reduced forms of the bacteria, which stimulate the body\'s immune system to produce antibodies without causing the diseases themselves. The vaccines play a crucial role in preventing serious complications and fatalities associated with diphtheria, tetanus, and pertussis.

This report provides a deep insight into the global DTaP and Tdap Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global DTaP and Tdap Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the DTaP and Tdap Vaccines market in any manner.
Global DTaP and Tdap Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US
Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co.
Ltd
AstraZeneca
Emergent BioSolutions Inc

Market Segmentation (by Type)
DTaP
Td
Tdap

Market Segmentation (by Application)
Adult
Pediatric

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the DTaP and Tdap Vaccines Market
Overview of the regional outlook of the DTaP and Tdap Vaccines Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the DTaP and Tdap Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of DTaP and Tdap Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of DTaP and Tdap Vaccines
      1.2 Key Market Segments
            1.2.1 DTaP and Tdap Vaccines Segment by Type
            1.2.2 DTaP and Tdap Vaccines Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 DTaP and Tdap Vaccines Market Overview
      2.1 Global Market Overview
            2.1.1 Global DTaP and Tdap Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global DTaP and Tdap Vaccines Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 DTaP and Tdap Vaccines Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global DTaP and Tdap Vaccines Product Life Cycle
      3.3 Global DTaP and Tdap Vaccines Sales by Manufacturers (2020-2025)
      3.4 Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturers (2020-2025)
      3.5 DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global DTaP and Tdap Vaccines Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 DTaP and Tdap Vaccines Market Competitive Situation and Trends
            3.8.1 DTaP and Tdap Vaccines Market Concentration Rate
            3.8.2 Global 5 and 10 Largest DTaP and Tdap Vaccines Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 DTaP and Tdap Vaccines Industry Chain Analysis
      4.1 DTaP and Tdap Vaccines Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of DTaP and Tdap Vaccines Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global DTaP and Tdap Vaccines Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to DTaP and Tdap Vaccines Market
      5.7 ESG Ratings of Leading Companies
  6 DTaP and Tdap Vaccines Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global DTaP and Tdap Vaccines Sales Market Share by Type (2020-2025)
      6.3 Global DTaP and Tdap Vaccines Market Size Market Share by Type (2020-2025)
      6.4 Global DTaP and Tdap Vaccines Price by Type (2020-2025)
  7 DTaP and Tdap Vaccines Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global DTaP and Tdap Vaccines Market Sales by Application (2020-2025)
      7.3 Global DTaP and Tdap Vaccines Market Size (M USD) by Application (2020-2025)
      7.4 Global DTaP and Tdap Vaccines Sales Growth Rate by Application (2020-2025)
  8 DTaP and Tdap Vaccines Market Sales by Region
      8.1 Global DTaP and Tdap Vaccines Sales by Region
            8.1.1 Global DTaP and Tdap Vaccines Sales by Region
            8.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Region
      8.2 Global DTaP and Tdap Vaccines Market Size by Region
            8.2.1 Global DTaP and Tdap Vaccines Market Size by Region
            8.2.2 Global DTaP and Tdap Vaccines Market Size Market Share by Region
      8.3 North America
            8.3.1 North America DTaP and Tdap Vaccines Sales by Country
            8.3.2 North America DTaP and Tdap Vaccines Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe DTaP and Tdap Vaccines Sales by Country
            8.4.2 Europe DTaP and Tdap Vaccines Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region
            8.5.2 Asia Pacific DTaP and Tdap Vaccines Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America DTaP and Tdap Vaccines Sales by Country
            8.6.2 South America DTaP and Tdap Vaccines Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Region
            8.7.2 Middle East and Africa DTaP and Tdap Vaccines Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 DTaP and Tdap Vaccines Market Production by Region
      9.1 Global Production of DTaP and Tdap Vaccines by Region(2020-2025)
      9.2 Global DTaP and Tdap Vaccines Revenue Market Share by Region (2020-2025)
      9.3 Global DTaP and Tdap Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America DTaP and Tdap Vaccines Production
            9.4.1 North America DTaP and Tdap Vaccines Production Growth Rate (2020-2025)
            9.4.2 North America DTaP and Tdap Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe DTaP and Tdap Vaccines Production
            9.5.1 Europe DTaP and Tdap Vaccines Production Growth Rate (2020-2025)
            9.5.2 Europe DTaP and Tdap Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan DTaP and Tdap Vaccines Production (2020-2025)
            9.6.1 Japan DTaP and Tdap Vaccines Production Growth Rate (2020-2025)
            9.6.2 Japan DTaP and Tdap Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China DTaP and Tdap Vaccines Production (2020-2025)
            9.7.1 China DTaP and Tdap Vaccines Production Growth Rate (2020-2025)
            9.7.2 China DTaP and Tdap Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Sanofi Pasteur
            10.1.1 Sanofi Pasteur Basic Information
            10.1.2 Sanofi Pasteur DTaP and Tdap Vaccines Product Overview
            10.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Product Market Performance
            10.1.4 Sanofi Pasteur Business Overview
            10.1.5 Sanofi Pasteur SWOT Analysis
            10.1.6 Sanofi Pasteur Recent Developments
      10.2 GlaxoSmithKline
            10.2.1 GlaxoSmithKline Basic Information
            10.2.2 GlaxoSmithKline DTaP and Tdap Vaccines Product Overview
            10.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Product Market Performance
            10.2.4 GlaxoSmithKline Business Overview
            10.2.5 GlaxoSmithKline SWOT Analysis
            10.2.6 GlaxoSmithKline Recent Developments
      10.3 Protein Sciences Corporation
            10.3.1 Protein Sciences Corporation Basic Information
            10.3.2 Protein Sciences Corporation DTaP and Tdap Vaccines Product Overview
            10.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Product Market Performance
            10.3.4 Protein Sciences Corporation Business Overview
            10.3.5 Protein Sciences Corporation SWOT Analysis
            10.3.6 Protein Sciences Corporation Recent Developments
      10.4 Novartis AG
            10.4.1 Novartis AG Basic Information
            10.4.2 Novartis AG DTaP and Tdap Vaccines Product Overview
            10.4.3 Novartis AG DTaP and Tdap Vaccines Product Market Performance
            10.4.4 Novartis AG Business Overview
            10.4.5 Novartis AG Recent Developments
      10.5 Seqirus
            10.5.1 Seqirus Basic Information
            10.5.2 Seqirus DTaP and Tdap Vaccines Product Overview
            10.5.3 Seqirus DTaP and Tdap Vaccines Product Market Performance
            10.5.4 Seqirus Business Overview
            10.5.5 Seqirus Recent Developments
      10.6 Merck Sharp and Dohme Corp
            10.6.1 Merck Sharp and Dohme Corp Basic Information
            10.6.2 Merck Sharp and Dohme Corp DTaP and Tdap Vaccines Product Overview
            10.6.3 Merck Sharp and Dohme Corp DTaP and Tdap Vaccines Product Market Performance
            10.6.4 Merck Sharp and Dohme Corp Business Overview
            10.6.5 Merck Sharp and Dohme Corp Recent Developments
      10.7 Astellas Pharma US
            10.7.1 Astellas Pharma US Basic Information
            10.7.2 Astellas Pharma US DTaP and Tdap Vaccines Product Overview
            10.7.3 Astellas Pharma US DTaP and Tdap Vaccines Product Market Performance
            10.7.4 Astellas Pharma US Business Overview
            10.7.5 Astellas Pharma US Recent Developments
      10.8 Inc
            10.8.1 Inc Basic Information
            10.8.2 Inc DTaP and Tdap Vaccines Product Overview
            10.8.3 Inc DTaP and Tdap Vaccines Product Market Performance
            10.8.4 Inc Business Overview
            10.8.5 Inc Recent Developments
      10.9 Pfizer Inc
            10.9.1 Pfizer Inc Basic Information
            10.9.2 Pfizer Inc DTaP and Tdap Vaccines Product Overview
            10.9.3 Pfizer Inc DTaP and Tdap Vaccines Product Market Performance
            10.9.4 Pfizer Inc Business Overview
            10.9.5 Pfizer Inc Recent Developments
      10.10 Johnson and Johnson
            10.10.1 Johnson and Johnson Basic Information
            10.10.2 Johnson and Johnson DTaP and Tdap Vaccines Product Overview
            10.10.3 Johnson and Johnson DTaP and Tdap Vaccines Product Market Performance
            10.10.4 Johnson and Johnson Business Overview
            10.10.5 Johnson and Johnson Recent Developments
      10.11 Lanzhou Institute of Biological Products Co.
            10.11.1 Lanzhou Institute of Biological Products Co. Basic Information
            10.11.2 Lanzhou Institute of Biological Products Co. DTaP and Tdap Vaccines Product Overview
            10.11.3 Lanzhou Institute of Biological Products Co. DTaP and Tdap Vaccines Product Market Performance
            10.11.4 Lanzhou Institute of Biological Products Co. Business Overview
            10.11.5 Lanzhou Institute of Biological Products Co. Recent Developments
      10.12 Ltd
            10.12.1 Ltd Basic Information
            10.12.2 Ltd DTaP and Tdap Vaccines Product Overview
            10.12.3 Ltd DTaP and Tdap Vaccines Product Market Performance
            10.12.4 Ltd Business Overview
            10.12.5 Ltd Recent Developments
      10.13 AstraZeneca
            10.13.1 AstraZeneca Basic Information
            10.13.2 AstraZeneca DTaP and Tdap Vaccines Product Overview
            10.13.3 AstraZeneca DTaP and Tdap Vaccines Product Market Performance
            10.13.4 AstraZeneca Business Overview
            10.13.5 AstraZeneca Recent Developments
      10.14 Emergent BioSolutions Inc
            10.14.1 Emergent BioSolutions Inc Basic Information
            10.14.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Overview
            10.14.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Market Performance
            10.14.4 Emergent BioSolutions Inc Business Overview
            10.14.5 Emergent BioSolutions Inc Recent Developments
  11 DTaP and Tdap Vaccines Market Forecast by Region
      11.1 Global DTaP and Tdap Vaccines Market Size Forecast
      11.2 Global DTaP and Tdap Vaccines Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe DTaP and Tdap Vaccines Market Size Forecast by Country
            11.2.3 Asia Pacific DTaP and Tdap Vaccines Market Size Forecast by Region
            11.2.4 South America DTaP and Tdap Vaccines Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of DTaP and Tdap Vaccines by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global DTaP and Tdap Vaccines Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of DTaP and Tdap Vaccines by Type (2026-2033)
            12.1.2 Global DTaP and Tdap Vaccines Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of DTaP and Tdap Vaccines by Type (2026-2033)
      12.2 Global DTaP and Tdap Vaccines Market Forecast by Application (2026-2033)
            12.2.1 Global DTaP and Tdap Vaccines Sales (K MT) Forecast by Application
            12.2.2 Global DTaP and Tdap Vaccines Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US
Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co.
Ltd
AstraZeneca
Emergent BioSolutions Inc
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400